AFFORDABLE MEDICINE COMPANY
DEAD

Serial Number

97844550

Owner

AMNEAL PHARMACEUTICALS LLC

Attorney

Janet W. Cho

Filing Date

Mar 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AFFORDABLE MEDICINE COMPANY Trademark

Serial Number: 97844550

AFFORDABLE MEDICINE COMPANY is a trademark filed by AMNEAL PHARMACEUTICALS LLC on March 17, 2023. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

AMNEAL PHARMACEUTICALS LLC (117 trademarks)

Third Floor
Bridgewater, NJ 08807

Entity Type: 16

Trademark Details

Filing Date

March 17, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical services, namely, processing online, telephone, and over-the-counter purchase orders for retail and central fill pharmacies and health care facilities and health care organizations, distributorship services and business development, all of the foregoing in the field of prescription and over-the-counter pharmaceutical preparations for humans

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 25, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 25, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 6, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 6, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 13, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 13, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 13, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 30, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 30, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023 NWOS
NEW APPLICATION ENTERED
Mar 21, 2023 NWAP